| | Greg Yothers, PhD
Research Assistant Professor, Biostatistics
Statistician, NSABP EducationB.S., Pennsylvania State University
M.A., University of Pittsburgh
Ph.D., University of Pittsburgh Research Interests My research thus far is aimed at the general problem of identifying subsets of a population where treatments have a significant difference. I also am involved in applied statistics with the National Surgical Adjuvant Breast and Bowel Project (NSABP). I am responsible for managing the NSABP's colorectal clinical trials program and I have some responsibilities in the Quality of Life program ofresearch. Selected Publications Romond EH, Perez EA, Bryant J, Suman V, Geyer Jr. CE, Davidson N, Tan-Chiu E, Martino S, Paik S, Kaufman P, Swain SM, Pisansky T, Fehrenbacher L, utteh LA, Vogel V, Visscher D, Yothers G, Jenkins R, Brown AM, Dakhil SR, Mamounas EP, Lingle WL, Klein PM, Ingle JN, and Wolmark N, Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer, New England Journal of Medicine, Accepted. Allegra CJ, Hall R, and Yothers G, Prevalence of Burnout in the United States Oncology Community, Journal of Oncology Practice, Accepted. Tan-Chiu E, Yothers G, Romond EH, Bryant J, Geyer Jr. CE, Ewer M, Keefe D, Shannon R, Swain SM, Brown AM, Fehrenbacher L, Vogel V, SeayTE, Mamounas EP, and Wolmark N, Assessment of Cardiac Dysfunction in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel to AC Followed by Paclitaxel Plus Trastuzumab as Adjuvant Therapy for Patients With Node-Positive, HER2-Overexpressing Breast Cancer, Journal of Clinical Oncology, Accepted. Mamounas EP, Bryant J, Lembersky B, Fehrenbacher L, Sedlacek SM, Fisher B, Wickerham DL, Yothers G, Soran A, and Wolmark N, Paclitaxel After Doxorubicin Plus Cyclophosphamide As Adjuvant Chemotherapy for Node-Positive Breast Cancer: Results From NSABP B-28, Journal of Clinical Oncology, Vol. 23, No. 16, June 1, 2005: 3686-96. Land SR, Kopec JA, Yothers G, Anderson S, Day R, Tang G, Ganz PA, Fisher B, and Wolmark N, Health-Related Quality of Life in Axillary Node-Negative, Estrogen Receptor-Negative Breast Cancer Patients Undergoing AC versus CMF Chemotherapy: Findings from the National Adjuvant Breast and Bowel Project B-23, Breast Cancer Research and Treatment, Vol. 86, No. 2, July 2004: 153-64. Yothers G and Sampson AR , Inference Guided Data Exploration, in Balakrishnan N, Kannan N, Nagaraja HN (Eds). Advances in Ranking and Selection, Multiple Comparisons and Reliability, Boston : Birkhauser, 2004: 47-64. Presentations "NSABP Protocol C-08", American Society for Clinical Oncology, Special Session titled "High-Priority Cooperative Group Phase III Trials for Community Practitioners", June 2004. "Statistical considerations in the design of NSABP Protocol C-08", NSABP
Fall Meeting, General Scientific Session, October 2002. "NSABP Protocol B-23 Quality of Life Outcomes", NSABP Behavioral and Health Outcomes Committee, June 2001. "Controlling the Experimentwise Type I Error Rate when Survival Analyses are Planned for Subsets of the Sample", University of Pittsburgh Department of Biostatistics Seminar, September 2000. "Excess Zeros", Session Chair, Joint Statistical Meetings, August 2000. Contact Information NSABP Biostatistical Center
201 North Craig Street, Suite 350
Pittsburgh, PA 15213
Telephone: 412-383-2558
Facsimile: 412-383-1387
Email: Yothers at nsabp.pitt.edu |  |
